The Predictive and Prognostic Factors in Patients with Gastric Cancer Accompanied by Gastric Outlet Obstruction
Table 1
Clinicopathological features and treatment-related factors of the patients with and without GOO groups.
Variables
GOO (157)
Without GOO (1407)
/ value
Gender
0.224
Male
120/76.4%
1011/71.9%
Female
37/23.6%
396/28.1%
Age (years) mean, SD※
≤0.001
Tumor size (cm) mean, SD
0.006
Hb# (g/L), mean, SD
0.996
Prealbumin (mg/L) mean, SD
≤0.001
Albumin (g/L) mean, SD
0.79
Stage N+
≤0.001
N0
33/21%
382/27.1%
N1
20/12.7%
334/23.7%
N2
19/12.1%
367/26.1%
N3a
35/22.3%
145/10.3%
N3b
25/15.9%
38/2.7%
NX
25/15.9%
141/10.0%
Stage T
≤0.001
T1
3/1.9%
138/9.8%
T2
20/12.7%
305/21.7%
T3
2/1.3%
45/3.2%
T4a
69/43.9%
524/37.2%
T4b
63/40.1%
395/28.1%
Surgery
0.005
Radical resection
100/63.7%
1037/73.7%
Nonradical resection
36/22.9%
225/16.0%
Gastrojejunostomy
20/12.7%
108/7.7%
Laparotomy
1/0.6%
37/2.6%
Macroscopic type
0.002
EGC@
1/0.6%
59/4.3%
Borrmann I
5/3.2%
120/8.7%
Borrmann II
12/7.6%
114/8.3%
Borrmann III
92/58.6%
819/59.5%
Borrmann IV
20/12.7%
126/9.2%
27/17.2%
139/10.1%
Differentiation
0.181
Well
7/4.5%
44/3.1%
Moderate
45/28.7%
452/32.1%
Poor
81/51.6%
652/46.3%
Mucinous
8/5.1%
71/5.0%
Signet
11/7.0%
73/5.2%
5/3.2%
115/8.2%
Peritoneal metastasis
0.007
No
139/88.5%
1331/94.6%
Yes
18/11.5%
76/5.4%
T1 tumor has invaded the mucosa or submucosa layer; T2 tumor has invaded the muscular layer; T3 tumor has invaded the subserosa; T4a: tumor has invaded the serosa or penetrating serosa; T4b: tumor invaded the adjacent organs; +N0 no regional lymph node metastasis; N1 1-2 regional lymph node metastasis; N2 3-6 regional lymph node metastasis; and N3a 7-15 regional lymph node metastasis; N3b ≥15 regional lymph node metastasis. ※SD standard deviation; #Hb hemoglobin; @EGC early gastric cancer; unknown type.
